Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication April 19, 2013
- Accepted for publication October 28, 2013
- Published online March 3, 2014.
Article Versions
- previous version (February 13, 2014 - 06:05).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Olof Eriksson1,
- Ram K. Selvaraju1,
- Lars Johansson2,3,
- Jan W. Eriksson3,4,
- Anders Sundin5,
- Gunnar Antoni2,
- Jens Sörensen2,
- Barbro Eriksson4 and
- Olle Korsgren6
- 1Department of Medicinal Chemistry, Preclinical PET Platform, Uppsala University, Uppsala, Sweden
- 2Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden
- 3AstraZeneca R&D, Mölndal, Sweden
- 4Department of Medical Sciences, Uppsala University, Uppsala, Sweden
- 5Department of Radiology, Karolinska University Hospital, Stockholm, Sweden; and
- 6Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
- For correspondence or reprints contact: Olof Eriksson, Preclinical PET Platform (PPP), Department of Medicinal Chemistry, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden. E-mail: olof.eriksson{at}pet.medchem.uu.se
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Longitudinal Assessment of 11C-5-Hydroxytryptophan Uptake in Pancreas After Debut of Type 1 Diabetes
- Evaluation of PET Brain Radioligands for Imaging Pancreatic {beta}-Cell Mass: Potential Utility of 11C-(+)-PHNO
- Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation
- Positron Emission Tomography Ligand [11C]5-Hydroxy-Tryptophan Can Be Used as a Surrogate Marker for the Human Endocrine Pancreas